Susquehanna International Group’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-106,300
| Closed | -$491K | – | 11221 |
|
|
2019
Q1 | $491K | Buy |
106,300
+81,500
| +329% | +$386K | ﹤0.01% | 6324 |
|
|
2018
Q4 | $87K | Sell |
24,800
-168,400
| -87% | -$1.17M | ﹤0.01% | 8281 |
|
|
2018
Q3 | $1.95M | Sell |
193,200
-61,200
| -24% | -$488K | ﹤0.01% | 4041 |
|
|
2018
Q2 | $1.84M | Buy |
254,400
+64,200
| +34% | +$448K | ﹤0.01% | 4148 |
|
|
2018
Q1 | $1.15M | Buy |
190,200
+60,700
| +47% | +$501K | ﹤0.01% | 4964 |
|
|
2017
Q4 | $1.25M | Sell |
129,500
-46,100
| -26% | -$302K | ﹤0.01% | 4799 |
|
|
2017
Q3 | $1.56M | Sell |
175,600
-200
| -0.1% | -$2.06K | ﹤0.01% | 4380 |
|
|
2017
Q2 | $2.22M | Sell |
175,800
-25,600
| -13% | -$303K | ﹤0.01% | 3731 |
|
|
2017
Q1 | $2.12M | Buy |
201,400
+74,300
| +58% | +$792K | ﹤0.01% | 3625 |
|
|
2016
Q4 | $1.17M | Buy |
127,100
+19,000
| +18% | +$215K | ﹤0.01% | 5184 |
|
|
2016
Q3 | $1.27M | Buy |
108,100
+34,600
| +47% | +$526K | ﹤0.01% | 4341 |
|
|
2016
Q2 | $951K | Sell |
73,500
-169,000
| -70% | -$2.46M | ﹤0.01% | 4981 |
|
|
2016
Q1 | $3.88M | Sell |
242,500
-36,400
| -13% | -$691K | ﹤0.01% | 2657 |
|
|
2015
Q4 | $7.99M | Buy |
278,900
+73,600
| +36% | +$2.04M | ﹤0.01% | 1986 |
|
|
2015
Q3 | $5.84M | Sell |
205,300
-88,800
| -30% | -$3.27M | ﹤0.01% | 2459 |
|
|
2015
Q2 | $10.6M | Buy |
294,100
+100,500
| +52% | +$3.13M | ﹤0.01% | 1938 |
|
|
2015
Q1 | $5.63M | Sell |
193,600
-96,400
| -33% | -$2.55M | ﹤0.01% | 2573 |
|
|
2014
Q4 | $6.11M | Sell |
290,000
-16,200
| -5% | -$320K | ﹤0.01% | 2612 |
|
|
2014
Q3 | $5.94M | Buy |
306,200
+209,000
| +215% | +$3.28M | ﹤0.01% | 2777 |
|
|
2014
Q2 | $1.52M | Sell |
97,200
-36,300
| -27% | -$587K | ﹤0.01% | 5213 |
|
|
2014
Q1 | $2.77M | Buy |
133,500
+61,800
| +86% | +$1.23M | ﹤0.01% | 3782 |
|
|
2013
Q4 | $925K | Buy |
+71,700
| New | +$994K | ﹤0.01% | 5646 |
|
Other funds holding INSY
WS
Susquehanna International Group's INSY Position: Q2 2019 in Review
Susquehanna International Group sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 21,561 shares — an estimated $100K sold.
Susquehanna International Group first reported a position in INSY in Q2 2014 and held it in 13 quarters. The position peaked at $1.87M in Q3 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Susquehanna International Group reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Susquehanna International Group sold 21,561 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $100K.
- Susquehanna International Group first reported a position in Insys Therapeutics, Inc. in Q2 2014 and held it in 13 quarters.
- Susquehanna International Group's Insys Therapeutics, Inc. position peaked at $1.87M in Q3 2015.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.